Skip to content

PrEP researchers now focusing on the best ways to get PrEP to people who need it

Linda-Gail Bekker presenting at AIDS 2016. Photo©International AIDS Society/Steve Forrest/Workers' Photos

Respect our rights and we can end HIV!

Respect our rights and we can end HIV!

Opioid substitution therapy improves many ART-related outcomes among people who inject drugs

Most young MSM and transgender women, including those with HIV, would benefit from HPV vaccination

Incidence of liver cancer is increasing in people with HIV/HCV co-infection

Switching from tenofovir DF to TAF improves bone and kidney safety

Feasible to prescribe ART to emergency department patients with suspected acute HIV infection

HIV seroconversion is rare if Truvada PrEP is used consistently

Slide from Gilead presentation at ASM Microbe 2016.

New integrase inhibitor bictegravir looks promising in early studies